Lumov, a direct-to-consumer (D2C) orthopaedic products startup, is reportedly in discussions to raise approximately ₹33 crore ($3.5 million) in a funding round led by Peak XV’s Surge programme. The proposed investment is also expected to include participation from the company’s existing investors.
Founded in 2024 by Saumaric Dangwal and Ankit Gupta, Lumov designs and manufactures orthopaedic support products for post-surgical recovery, rehabilitation, and pain management.
Both founders bring professional experience in private equity. Dangwal previously worked at Bain Capital, where he invested in the healthcare and consumer sectors, while Gupta has worked with Brookfield Private Equity and Steinberg Asset Management.
Lumov’s product portfolio includes knee braces, insoles, and lower-back support belts. The company follows a direct-to-consumer business model through its website and also distributes its products through e-commerce and quick-commerce platforms such as Flipkart and Blinkit.
The startup claims to collaborate with orthopaedic specialists from Manipal Hospitals, Apollo Hospitals, Sakra World Hospital, and AIG Hospitals to develop its products. Additionally, Lumov focuses on designing solutions tailored to Indian patients and local climatic conditions.
Before the proposed fundraise, Lumov secured $1.2 million (approximately ₹10 crore) in a seed funding round led by Incubate Fund Asia. The round also attracted investments from QRG Investments and Holdings, the family office of Havells, IIMA Ventures, SIDBI, and several angel investors, including Ashish Gupta of Helion Advisors, Saket Narang of Steinberg India, and Abhishek Goyal of Tracxn.
Following the seed investment, Lumov outlined plans to strengthen its manufacturing capabilities, expand its sales operations, and introduce additional products for post-surgical recovery and rehabilitation. The company also planned to increase its presence across Delhi NCR, Hyderabad, and Mumbai while developing more clinical and sales partnerships.
The proposed funding comes amid growing investor interest in musculoskeletal healthcare and pain management solutions. In September, Bengaluru-based preventive pain care brand Betterhood raised ₹11.5 crore in a seed funding round led by Sauce VC.
Other companies in the pain management and rehabilitation segment have also attracted investor interest. In January, chronic pain clinic chain Nivaan Care raised $7 million in a Series A funding round led by Sorin Investments to expand its chronic pain management services.



